| Melissa Jane Puntkattalee, | |
|
5720 1st Ave S, Birmingham, AL 35212-2522 | |
| (205) 380-9455 | |
| (205) 380-9459 |
| Full Name | Melissa Jane Puntkattalee |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 5720 1st Ave S, Birmingham, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033679972 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD.48133 (Alabama) | Primary |
| Entity Name | Christ Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821234246 PECOS PAC ID: 9931106986 Enrollment ID: O20061103000498 |
News Archive
The UK National Health Service could save millions of pounds a year by routinely using inexpensive dressings to treat venous leg ulcers, after a study published in the October issue of BJS showed that they are just as effective as expensive silver dressings in the majority of cases.
Corventis, Inc., a developer of wireless cardiovascular solutions designed to enable early detection, prevention and treatment of cardiovascular conditions, announced today enrollment completion of the company's MUSIC (Multi-Sensor Monitoring in Congestive Heart Failure) program consisting of 2 trials: the MUSIC Asia (180 patients) and the pivotal MUSIC study (362 patients).
Dendreon Corporation today announced that the U.S. Food and Drug Administration (FDA) provided written acknowledgement that the Company's amended Biologics License Application (BLA) for PROVENGE® (sipuleucel-T) is a complete response. The FDA has assigned a Prescription Drug User Fee Act (PDUFA) date of May 1, 2010, by which time it will respond to Dendreon's amended BLA. Dendreon is seeking licensure for PROVENGE for men with metastatic castrate-resistant prostate cancer (CRPC).
Nearly 60 per cent of the public in England thinks that the cost of social care in later life should be shared by the state and the individual, even for people with substantial resources, according to joint research by the London School of Economics and Political Science and the London School of Hygiene & Tropical Medicine .
BioNano Genomics, the leader in genome mapping, announced today that The Scientist named the Company's IrysChip™ V2 one of the Top 10 Innovations of 2014.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melissa Jane Puntkattalee, 5720 1st Ave S, Birmingham, AL 35212-2522 Ph: (205) 380-9455 | Melissa Jane Puntkattalee, 5720 1st Ave S, Birmingham, AL 35212-2522 Ph: (205) 380-9455 |
News Archive
The UK National Health Service could save millions of pounds a year by routinely using inexpensive dressings to treat venous leg ulcers, after a study published in the October issue of BJS showed that they are just as effective as expensive silver dressings in the majority of cases.
Corventis, Inc., a developer of wireless cardiovascular solutions designed to enable early detection, prevention and treatment of cardiovascular conditions, announced today enrollment completion of the company's MUSIC (Multi-Sensor Monitoring in Congestive Heart Failure) program consisting of 2 trials: the MUSIC Asia (180 patients) and the pivotal MUSIC study (362 patients).
Dendreon Corporation today announced that the U.S. Food and Drug Administration (FDA) provided written acknowledgement that the Company's amended Biologics License Application (BLA) for PROVENGE® (sipuleucel-T) is a complete response. The FDA has assigned a Prescription Drug User Fee Act (PDUFA) date of May 1, 2010, by which time it will respond to Dendreon's amended BLA. Dendreon is seeking licensure for PROVENGE for men with metastatic castrate-resistant prostate cancer (CRPC).
Nearly 60 per cent of the public in England thinks that the cost of social care in later life should be shared by the state and the individual, even for people with substantial resources, according to joint research by the London School of Economics and Political Science and the London School of Hygiene & Tropical Medicine .
BioNano Genomics, the leader in genome mapping, announced today that The Scientist named the Company's IrysChip™ V2 one of the Top 10 Innovations of 2014.
› Verified 7 days ago
Mrs. Kathleen M Dupper, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1687 Center Point Pkwy Ste 121, Birmingham, AL 35215 Phone: 205-557-7022 Fax: 205-831-2849 | |
Jill Marsh, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Jack Cannon Whites, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 616 South 9th Street, Birmingham, AL 35233 Phone: 205-326-3100 Fax: 205-716-3044 | |
Dr. Kathryn D Kartus, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3900 Seven Bark Cir, Birmingham, AL 35243 Phone: 205-967-6676 | |
Dr. Nova Law, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 944 18th St S, Suite C, Birmingham, AL 35205 Phone: 205-870-4343 Fax: 205-870-0299 | |
Sarah Kane, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1308 Tuscaloosa Ave Sw, Birmingham, AL 35211 Phone: 205-679-6325 Fax: 205-783-8600 |